Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Journal of Korean Medical Science|June 18, 2013
Genome-wide association study of lung cancer in Korean non-smoking womenJin Hee Kim, Kyunghee Park, Seon-Hee Yim, et al.
NPJ Vaccines|January 28, 2022
Immune persistence and response to booster dose of Vi-DT vaccine at 27.5 months post-first doseMaria Rosario Capeding, Birkneh Tilahun Tadesse, Arijit Sil, et al.
Msphere|December 26, 2024
Dose-dependent serological profiling of AdCLD-CoV19-1 vaccine in adultsJung Hyuk Lee, Yuna Shin, Kwang-Soo Shin, et al.
Vaccine|May 20, 2018
Safety and immunogenicity of a Vi-DT typhoid conjugate vaccine: Phase I trial in Healthy Filipino adults and childrenMaria Rosario Capeding, Samuel Teshome, Tarun Saluja, et al.
Eclinicalmedicine|November 5, 2020
Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: Phase II, randomized, dose-scheduling, observer-blind StudyMaria Rosario Capeding, Arijit Sil, Birkneh Tilahun Tadesse, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2025
Real-world Evaluation of the Effectiveness of Sinopharm COVID-19 Vaccine Against Symptomatic COVID-19 in an Omicron-Dominant Setting in Mozambique: A Test-Negative, Case-Control StudyIgor Ubisse Capitine, Asma Binte Aziz, Alvaro Manhiça, et al.
Vaccine|December 31, 2021
A non-inferiority trial comparing two killed, whole cell, oral cholera vaccines (Cholvax vs. Shanchol) in Dhaka, BangladeshFahima Chowdhury, Afroza Akter, Taufiqur Rahman Bhuiyan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2025
Immunogenicity and Safety of Heterologous Versus Homologous Prime-Boost Regimens With BBIBP-CorV and Ad26.COV2.S COVID-19 Vaccines: A Multicentric, Randomized, Observer-Blinded Non-inferiority Trial in Madagascar and MozambiquePatrícia Ramgi, Mohamadou Siribie, Njariharinjakamampionona Rakotozandrindrainy, et al.
Pageof 12